Literature DB >> 11911841

Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.

Kaoru Kobayashi1, Kikuko Urashima, Noriaki Shimada, Kan Chiba.   

Abstract

In this study, we performed a screening of the specificities of rat cytochrome P450 (CYP) isoforms for metabolic reactions known as the specific probes of human CYP isoforms, using 13 rat CYP isoforms expressed in baculovirus-infected insect cells or B-lymphoblastoid cells. Among the metabolic reactions studied, diclofenac 4-hydroxylation (DFH), dextromethorphan O-demethylation (DMOD) and midazolam 4-hydroxylation were specifically catalyzed by CYP2C6, CYP2D2 and CYP3A1/3A2, respectively. These results suggest that diclofenac 4-hydroxylation, dextromethorphan O-demethylation and midazolam 4-hydroxylation are useful as catalytic markers of CYP2C6, CYP2D2 and CYP3A1/3A2, respectively. On the other hand, phenacetin O-deethylation and 7-ethoxyresorufin O-deethylation were catalyzed both by CYP1A2 and by CYP2C6. Benzyloxyresorufin O-dealkylation and pentoxyresorufin O-dealkylation were also catalyzed by CYP1A2 in addition to CYP2B1. Bufuralol 1'-hydroxylation was extensively catalyzed by CYP2D2 but also by CYP2C6 and CYP2C11. p-Nitrophenol 2-hydroxylation and chlorzoxazone 6-hydroxylation were extensively catalyzed by CYP2E1 but also by CYP1A2 and CYP3A1. Therefore, it is necessary to conduct further study to clarify whether these activities in rat liver microsomes are useful as probes of rat CYP isoforms. In contrast, coumarin 7-hydroxylation and S- and R-mephenytoin 4'-hydroxylation did not show selectivity toward any isoforms of rat CYP studied. Therefore, activities of coumarin 7-hydroxylation and S- and R-mephenytoin 4'-hydroxylation are not able to be used as catalytic probes of CYP isoforms in rat liver microsomes. These results may provide useful information regarding catalytic probes of rat CYPs for studies using rat liver microsomal samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911841     DOI: 10.1016/s0006-2952(01)00843-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

1.  Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy.

Authors:  Leslie J Dickmann; Suzanne Tay; Tauri D Senn; Huixia Zhang; Anthony Visone; Jashvant D Unadkat; Mary F Hebert; Nina Isoherranen
Journal:  Biochem Pharmacol       Date:  2008-02-07       Impact factor: 5.858

2.  siRNA-mediated knockdown of P450 oxidoreductase in rats: a tool to reduce metabolism by CYPs and increase exposure of high clearance compounds.

Authors:  Rob S Burke; Inthirai Somasuntharam; Paul Rearden; Duncan Brown; Sujal V Deshmukh; Martha A DiPietro; Jillian DiMuzio; Roy Eisenhandler; Scott E Fauty; Christopher Gibson; Marian E Gindy; Kelly A Hamilton; Ian Knemeyer; Kenneth A Koeplinger; Hae Won Kwon; Traci Q Lifsted; Karsten Menzel; Mihir Patel; Nicole Pudvah; Deanne Jackson Rudd; Jessica Seitzer; Walter R Strapps; Thomayant Prueksaritanont; Charles D Thompson; Jerome H Hochman; Brian A Carr
Journal:  Pharm Res       Date:  2014-07-01       Impact factor: 4.200

3.  Treprostinil Improves Hepatic Cytochrome P450 Activity during Rat Liver Transplantation.

Authors:  Nisanne Ghonem; Junichi Yoshida; Noriko Murase; Stephen C Strom; Raman Venkataramanan
Journal:  J Clin Exp Hepatol       Date:  2012-10-12

4.  Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.

Authors:  M Dostalek; E Hadasova; M Hanesova; J Pistovcakova; A Sulcova; J Jurica; J Tomandl; I Linhart
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

5.  Inhibitory action of Epilobium hirsutum extract and its constituent ellagic acid on drug-metabolizing enzymes.

Authors:  Gurbet Celik; Aslı Semiz; Serdar Karakurt; Ayse Mine Gencler-Ozkan; Sevki Arslan; Orhan Adali; Alaattin Sen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-11-26       Impact factor: 2.441

6.  Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats.

Authors:  Su-Young Choi; Liam Fischer; Kyunghee Yang; Hyejin Chung; Hyunyoung Jeong
Journal:  Biochem Pharmacol       Date:  2011-01-08       Impact factor: 5.858

Review 7.  PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

Authors:  Ellen M McDonagh; Catherine Wassenaar; Sean P David; Rachel F Tyndale; Russ B Altman; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

8.  Influence of dietary fat type on benzo(a)pyrene [B(a)P] biotransformation in a B(a)P-induced mouse model of colon cancer.

Authors:  Deacqunita L Diggs; Jeremy N Myers; Leah D Banks; Mohammad S Niaz; Darryl B Hood; L Jackson Roberts; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2013-12       Impact factor: 6.048

9.  Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?

Authors:  Jiang Yue; Renxiu Peng
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  A mechanism-based integrated pharmacokinetic enzyme model describing the time course and magnitude of phenobarbital-mediated enzyme induction in the rat.

Authors:  Mats O Magnusson; Mats O Karlsson; Rikard Sandström
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.